FDA Moves Dissolvable Antibiotic Bone Filler to Class II
Published Date: 6/5/2026
Rule
Summary
The FDA is officially putting a special bone filler that slowly dissolves and fights bacteria into a safer, easier-to-manage category called Class II. This change helps make sure the product is safe and effective while speeding up patient access to this cool new tech. It’s been in effect since May 2022, so companies and patients can expect smoother approvals and fewer hoops to jump through.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
Easier FDA Path for Device Makers
The FDA has classified a resorbable calcium salt bone void filler with a single approved aminoglycoside antibacterial as Class II, effective June 5, 2026 (classification applicable May 17, 2022). That means the product can serve as a predicate device so other makers can use the less-burdensome 510(k) premarket notification pathway instead of automatic Class III premarket approval, which the FDA says will reduce regulatory burdens and help speed patient access.
More Patient Access to Bone Filler
You (patients) may get earlier access to a resorbable bone void filler intended to reduce recurrence of chronic osteomyelitis of long bones because FDA placed this product into Class II with special controls (order effective June 5, 2026; classification applicable May 17, 2022). The rule also lists required safety measures — such as clinical and animal testing, labeling about risks (including antimicrobial resistance and systemic adverse effects), and sterility and stability data — to provide reasonable assurance of safety and effectiveness.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11303 — Intent To Exempt Certain Unclassified Medical Devices From Premarket Notification Requirements; Guidance for Industry and Food and Drug Administration Staff; Availability
The FDA is planning to exempt some unclassified medical devices from the usual premarket notification rules, making it easier and faster for these devices to reach the market. This change affects manufacturers of certain medical devices and could save them time and money. The new guidance is effective starting June 5, 2026, but the FDA is still open to feedback from the public.
2026-11306 — Medical Devices; Orthopedic Devices; Classification of the Shoulder Joint Humeral (Hemi-Shoulder) Ceramic Head/Metallic Stem Cemented or Uncemented Prosthesis
The FDA is officially putting the shoulder joint humeral ceramic head/metallic stem prosthesis into Class II, meaning it now has special safety rules but fewer red tape hurdles. This change helps patients get safer, innovative shoulder implants faster and makes life easier for makers by lowering regulatory costs. The new classification is effective June 5, 2026, but has been in effect since December 16, 2022.
2026-11302 — Medical Devices; Orthopedic Devices; Classification of the Absorbable Metallic Bone Fixation Fastener
The FDA is officially classifying absorbable metallic bone fixation fasteners as Class II devices with special safety rules, making them easier to get to patients while keeping them safe and effective. This change helps doctors and patients by reducing red tape and encouraging new, helpful bone-fixing tech. The new rules took effect on June 5, 2026, but have been in place since March 29, 2023, so manufacturers should already be on board.
2026-11060 — Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities-Questions and Answers; Revised Draft Guidance for Industry; Availability
The FDA just released a revised draft guide to help drug and device makers share important cost and coverage info with insurance companies and similar groups. This update clears up how to talk about approved products, unapproved products, and new uses, making it easier for everyone to understand the rules. Companies should send their feedback by August 3, 2026, so the FDA can finalize the guide—potentially speeding up coverage decisions and saving money.
2026-11062 — Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications
The FDA is officially pulling the plug on 16 generic drug approvals because the companies told them these medicines aren’t being sold anymore. This change kicks in on July 6, 2026, and it won’t stop companies from trying again later if they want. If you’re a drug maker or just curious, this means fewer old approvals cluttering the books and a cleaner, fresher drug list.
2026-11101 — Third Annual Animal Drug User Fee Educational Conference; Public Meeting
The FDA is hosting its Third Annual Animal Drug User Fee Educational Conference on July 7, 2026, to help drug makers and animal health experts understand the new animal drug approval process. This free event is both in-person and online, making it easy to join. Stakeholders should register early and can send feedback within 90 days after the meeting to help shape future policies and fees.
Previous / Next Documents
Previous: 2026-11307 — Amendment of Class E Airspace; Springfield, KY
The FAA is updating the Class E airspace around Lebanon Springfield Airport in Springfield, KY, to match new flight procedures and correct the airport’s name and location info. This change helps pilots fly safely using instruments and kicks in on September 3, 2026. No extra costs for anyone—just smoother skies and clearer rules!
Next: 2026-11311 — Special Local Regulation; Genesee River, Rochester, NY
On June 20, 2026, the Coast Guard will temporarily block off part of the Genesee River in Rochester, NY, for a thrilling Harborfest Water Ski Show. Boats and people can’t enter the area from 11:45 a.m. to 5:30 p.m. unless they get special permission. This keeps everyone safe during the high-speed water fun without costing anyone a dime!